Bacordo, Helenda T.

HRN: 10-84-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/29/2026
02/05/2026
IV
3.375g
Q6Hrs
Sepsis, Complicated UTI
Pending Pharmacy Acceptance 

 Indication:  Empirical Escalation    Type of Infection:  Urinary TractBloodstream    Compliance to guidelines: